Report on the use of capital increase funds received from the offering of Common Shares to Private Placement (PP)
07/08/2025
Financial Statement Quarter 2/2025 (Reviewed)
14/08/2025

Notification of Resolutions of the Board of Directors’ Meeting No. 5/2025 regarding the Change of the Company’s Name, Stock Symbol, Logo, and Company Seal; and the Date for the Extraordinary General Meeting of Shareholders No. 1/2025

Schedule of Shareholders' meeting

 

Subject                                  : Schedule of Extra-General Meeting of

Shareholders

Date of Board resolution                 : 14-Aug-2025

Shareholder's meeting date               : 22-Oct-2025

Beginning time of meeting (hh:mm)        : 13 : 30

Record date for the right to attend the  : 05-Sep-2025

meeting

Ex-meeting date                          : 04-Sep-2025

Significant agenda item                  :

  - To amendment the company's article of association

  - To amendment the company's objectives

Venue of the meeting                     : Electronic 89 AIA Capital Center

Building, 9th Floor, Room 901, Din Daeng Subdistrict, Din Daeng District,

Bangkok, and/or at a location designated by the Company

 

Agenda Item                              : 1

Agenda Detail                            : To consider and adopt the minutes of

the Annual General Meeting of Shareholders 2025

Type                                     : To Consider and approve

Board's Resolution                       : Board's opinion: The Board deems it

appropriate to propose to the Extraordinary General Meeting of Shareholders No.

1/2025 to consider and approve the minutes of the Annual General Meeting of

Shareholders for the year 2025.

 

Agenda Item                              : 2

Agenda Detail                            : Consider and approve the amendment of

 company's article of association

Type                                     : To Consider and approve

Board's Resolution                       : Board's opinion:  The Board deems it

appropriate to propose to the Extraordinary General Meeting of Shareholders No.

1/2025 to approve the amendment of the Company's Articles of Association to be

consistent with the change of the Company's name and seal.

 

Agenda Item                              : 3

Agenda Detail                            : Consider and approve the amendment of

 company's objectives

Type                                     : To Consider and approve

Board's Resolution                       : Board's opinion:  The Board deems it

appropriate to propose to the Extraordinary General Meeting of Shareholders No.

1/2025 to approve the amendment of the Company's Memorandum of Association,

Clause 3, regarding the Company's objectives, from the existing 33 items to 35

items.

 

Agenda Item                              : 4

Agenda Detail                            : To consider and approve the change of

 the Company's name, stock symbol, logo, and company seal.

Type                                     : To Consider and approve

Board's Resolution                       : Board's opinion: The Board deems it

appropriate to propose to the Extraordinary General Meeting of Shareholders No.

1/2025 to approve the change of the Company's name, stock symbol, logo, and

company seal.

 

Agenda Item                              : 5

Agenda Detail                            : To consider and approve the amendment

of the Company's Memorandum of Association, Clause 1, regarding the Company's

name.

Type                                     : To Consider and approve

Board's Resolution                       : The Board deems it appropriate to

propose to the Extraordinary General Meeting of Shareholders No. 1/2025 to

approve the amendment of the Company's Memorandum of Association, Clause 1

 

Agenda Item                              : 6

Agenda Detail                            : Association, Clause 3, regarding the

Company's objectives

Item 34. To engage in the retail and wholesale business of cosmetics, dietary

supplements, medical devices, chemicals, or hazardous substances used in medical

 applications through online platforms and other platforms.

Item 35. To engage in the manufacturing, import, and export business of

cosmetics, dietary supplements, medical devices, chemicals, or hazardous

substances used in medical applications.

Type                                     : To Consider and approve

Board's Resolution                       : The Board deems it appropriate to

propose to the Extraordinary General Meeting of Shareholders No. 1/2025 to

approve the amendment of the Company's Memorandum of Association, Clause 3

 

______________________________________________________________________

More detail                              :

Twenty-Four Con & Supply Public Company Limited ("Company") would like to inform

you of the resolutions of the Board of Directors' Meeting No. 5/2025, held on

August 14, 2025. The meeting passed the following key resolutions:

To convene the for the Extraordinary General Meeting of Shareholders No. 1/2025,

which will be held on Wednesday, October 22, 2025, at 1:30 p.m. via electronic

means at the Company's head office located at 89 AIA Capital Center Building,

9th Floor, Room 901, Din Daeng Subdistrict, Din Daeng District, Bangkok, and/or

at a location designated by the Company. The Record Date for shareholders

entitled to attend the Extraordinary General Meeting of Shareholders No. 1/2025

will be on Friday, September 5, 2025. The meeting agenda was enclosed with this

file.

 

______________________________________________________________________

 

This announcement was prepared and disseminated by listed company or issuer

through the electronic system which is provided for the purpose of dissemination

of the information and related documents of listed company or issuer to the

Stock Exchange of Thailand only.  The Stock Exchange of Thailand has   no

responsibility for the correctness and completeness of any statements, figures,

reports or opinions contained in this announcement, and has no liability for any

losses and damages in any cases.  In case you have any inquiries or

clarification regarding this announcement, please directly contact listed

company or issuer who made this announcement.

 

If you would like to see the full details of this information, please click view

 "full details" in attached file.